SMS Pharmaceuticals Limited

SMS Pharmaceuticals Limited (SMSPHARMA) is a micro-cap Healthcare company valued at ₹4,209 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

SMS Pharmaceuticals Limited last traded at ₹446.65, sharply up 5.11% on the day.

Recent developments

On 2026-06-30, the company declared a dividend of ₹0.40 per share, with an ex-date of 2026-09-16, and another dividend of ₹0.40 per share with an ex-date of 2026-09-22. Promoter shares pledged increased to 17.99% of promoter holding as of 2026-06-30.

Financial performance

The company's business is improving, with annual revenue rising 13.3% and net profit surging 47.8% year-over-year. The latest quarter saw revenue grow 5.6% and net profit rise 4.6% compared to the same quarter a year earlier, while the net profit margin expanded 2.7 percentage points to 11.5%.

Valuation multiples

The stock trades at 40.1 times earnings, a premium to the Healthcare median of 32.0, 5.00 times book value. It yields 0.1%.

Things to watch

The stock is 4.7% below its 52-week high, and promoter shares pledged now account for 17.99% of promoter holding. The company's debt to equity ratio is 0.46, which is relatively low but still represents a leverage risk.

Where it stands

The company has shown strong growth in both revenue and net profit over the past year, with the net profit margin improving significantly. The latest quarter's results reflect continued growth, but the stock remains below its 52-week high. The promoter's pledged shares indicate potential liquidity concerns.

Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.